Genetic counseling of medullary breast cancer patients

Clinical Genetics

Volumn 65, Issue 4, 2004, Pages 343-344

  Kroupis, C ^b   Lianidou, E ^b   Goutas, N ^b   Vasilaros, S ^b   Yannoukakos, D ^b   Petersen, Michael B ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; KI 67 ANTIGEN;

BREAST CANCER; CANCER CLASSIFICATION; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CYTOMETRY; DNA ISOLATION; DNA SEQUENCE; FEMALE; GENE OVEREXPRESSION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; ONCOGENE C ERB; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; HUMANS;

EID: 1842581811     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2003.00231.x     Document Type: Letter

References (13)

1. Wooster R, Weber BL. Breast and ovarian cancer. N Engl J Med 2003: 348: 2339-2347.
2. Eisinger F, Jacquemier J, Charpin C et al. Mutations at BRCA1: The medullary breast carcinoma revisited. Cancer Res 1998: 58: 1588-1592.
3. Shousha S. Medullary carcinoma of the breast and BRCA1 mutation. Histopathology 2000: 37: 182-185.
4. Verhoog LC, Brekelmans CT, Seynaeve C et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998: 351: 316-321.
5. Iau PT, Macmillan RD, Blamey RW. Germ line mutations associated with breast cancer susceptibility. Eur J Cancer 2001: 37: 300-321.
6. Lidereau R, Eisinger F, Champeme MH et al. Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res 2000: 60: 1206-1210.
7. Quenneville LA, Phillips KA, Ozcelik H et al. HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry. Cancer 2002: 95: 2068-2075.
8. Johannsson OT, Idvall I, Anderson C et al. Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer 1997: 33: 362-371.
9. Lakhani SR, van de Vijver MJ, Jacquemier J et al, The pathology of familial breast cancer: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 2002: 20: 2310-2318.
10. Ladopoulou A, Kroupis C, Konstantopoulou. I et al. Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed. Cancer Lett 2002: 185: 61-70.
11. Kroupis C, Lianidou E, Goutas N et al. Atypical medullary breast carcinoma in a family carrying the 5382insC BRCA-1 mutation. Breast J 2003: 9: 260-262.
12. Ridolfi RL, Rosen PP, Port A et al. Medullary carcinoma of the breast: A clinicopathologic study with 10 year follow-up. Cancer 1977: 40: 1365-1385.
13. Rapin V, Contesso G, Mouriesse H et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 1988: 61: 2503-2510.